Question Bank › Promise already turning into fact

Promise already turning into fact

Promise already turning into fact: management shows the thing it told investors was coming is now measurably arriving, a

Calls Tested
309
Answered YES
46
Hit Rate
14.9%
rare by design

Atmos Energy Corporation (ATO) — this company's answers

NO on the Q1 2017 call 2017-02-08 A
The model's full reasoning — Q1 2017 call → NO我们根据提供的财报电话会议记录,判断管理层是否指出了之前告诉投资者会到来的增长性发展,并展示了当前实际活动证明该发展正在实现,同时表示这只是开始,大部分贡献还在后面。 分析记录内容: - 管理层提到“我们继续执行我们的战略,投资于受监管资产”,并提到资本支出计划($1.1B-$1.25B),以及“我们预计在2020财年实现每股收益4.10-4.40美元”的长期目标。 - 具体到增长性发展:管理层提到“我们继续强调和建立与监管机构的关系,并传达基础设施投资的重要性”,以及“截至昨天,费率结果已提供约2000万美元的年度运营增长,我们提交了待决案件,寻求约7800万美元的增长”。 - 更具体地,关于APT(Atmos Pipeline Texas)的费率案,管理层说:“我们已开始第六年执行我们的战略,通过投资受监管资产来增长。”并提到“我们预计本财年将再提交12至15个申请,寻求7000万至8000万美元的额外运营增长”。 - 关于增长性发展,管理层提到“我们继续增加客户,过去12个月净客户增长约0.8%或约24,000名客户”,以及“运输收入增长约200万美元,主要来自工业扩张和天然气需求增加”,例如田纳西州的通用汽车工厂扩张、肯塔基州的酿酒厂扩张、堪萨斯城的CNG车队等。 - 但关键问题是:管理层是否明确提到“之前告诉投资者会到来的增长性发展”?在记录中,管理层提到“我们已开始第六年执行我们的战略”,这暗示了之前有战略承诺。但具体到某个特定发展,如某个新项目或新市场,管理层是否明确说“正如我们之前所说”? - 在记录中,管理层提到“我们继续强调和建立与监管机构的关系”,以及“我们已开始第六年执行我们的战略”,但并没有明确说“我们之前告诉过你们这个增长会到来”这样的表述。管理层提到“我们预计本财年将再提交12至15个申请”,这是未来的计划,不是当前已实现的。 - 关于当前实际活动:管理层提到“费率结果已提供约2000万美元的年度运营增长”,这是当前已实现的。但这是否是之前承诺的增长?管理层说“我们继续执行我们的战略”,但并没有明确说“我们之前告诉过你们这个增长会到来”。 - 此外,管理层提到“我们已开始第六年执行我们的战略”,这暗示了之前有战略承诺,但并没有具体到某个增长性发展。 - 关于“仍然早期”:管理层提到“我们预计本财年将再提交12至15个申请”,这暗示了未来还有更多,但并没有明确说“这只是开始”。 - 总体来看,管理层描述了当前的良好业绩,但并没有明确提到一个之前承诺的具体增长性发展,并展示其正在实现且仍处于早期。管理层更多是在总结当前进展和未来计划,而不是在验证一个之前的具体承诺。 因此,答案应为NO。

← Back to the full ATO analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management point to a growth-bearing development in its business that IT HAD PREVIOUSLY TOLD INVESTORS TO EXPECT — and demonstrate, with real current-period activity, that this development is NOW ACTUALLY ARRIVING at or beyond the pace management had indicated, while ALSO conveying that the development is still early, with most of its contribution ahead? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent three-part pattern: (1) A PRIOR EXPECTATION MANAGEMENT ITSELF HAD SET. Management refers back — explicitly or in plain substance — to something about the growth of the business it had previously communicated or anticipated: a ramp, launch, recovery, adoption, expansion, capacity fill, customer conversion, or similar forward development it told investors was coming. The reference may be phrased in many ways ('as we said last quarter...', 'consistent with what we laid out...', 'we told you this would begin...', 'in line with the plan we described...'), so long as it concerns the business growing or inflecting — not a cost program, financing step, or routine housekeeping. (2) CURRENT REALITY IS NOW CONFIRMING IT. Management points to concrete activity in the just-reported period or happening now — actual orders, customers, volumes, shipments, deployments, utilization, openings, sign-ups, revenue from the new thing, or equivalent real events — as evidence that the anticipated development is materializing on schedule or faster/bigger than indicated. The confirmation must rest on things that already happened, described with enough substance that the arrival is observable rather than asserted. (3) MANAGEMENT SAYS IT IS STILL EARLY. Management conveys, directly or plainly in substance, that what has arrived so far is only the beginning of the development — the ramp is in its early innings, contribution to reported results is still small relative to what the same trajectory delivers ahead, further stages are already scheduled or in motion — so the reported numbers understate where the confirmed trajectory is already heading. The essence is ONE phenomenon: a management team that made a growth claim, is now standing in front of evidence that the claim is coming true, and is telling investors the verified trajectory has much further to run. The industry, the nature of the development, and the form of the evidence may vary widely. Answer NO if management describes promising developments with no indication it had previously set that expectation — a fresh announcement is not verification. NO if the look-back is only to beating financial guidance or consensus numbers, with no underlying operating development being confirmed. NO if the previously-promised item is a cost reduction, restructuring, refinancing, or housekeeping matter rather than a growth-bearing development. NO if the confirmation rests on pipeline, interest, letters of intent, or expectations rather than real current activity. NO if management indicates the development is now substantially complete or fully reflected in results, with little still ahead. NO if management is explaining that the anticipated development is late, smaller than expected, or being walked back. NO if the pattern appears only in an analyst's question or summary that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
MCD McDonald's Corporation Q2 2024 2024-07-29 D
AES The AES Corporation Q1 2024 2024-05-03 C+
ASB Associated Banc-Corp Q1 2024 2024-04-25 A
DUOT Duos Technologies Group, Inc. Q4 2023 2024-04-01 F
HP Helmerich & Payne, Inc. Q1 2024 2024-01-30 C
SCPH scPharmaceuticals Inc. Q3 2023 2023-11-08 B
SITM SiTime Corporation Q2 2023 2023-08-02 C+
DKS DICK'S Sporting Goods, Inc. Q4 2022 2023-03-07 B
XHR Xenia Hotels & Resorts, Inc. Q2 2022 2022-08-05 A
BRKL Brookline Bancorp, Inc. Q2 2022 2022-07-30 B+
UPWK Upwork Inc. Q2 2022 2022-07-27 C+
KD Kyndryl Holdings, Inc. Q4 2021 2022-03-01 C+
EXP Eagle Materials Inc. Q3 2022 2022-01-27 B
WES Western Midstream Partners, LP Q3 2018 2018-10-31 D
MAS Masco Corporation Q3 2018 2018-10-30 C
AU AngloGold Ashanti's Q2 2018 2018-08-20 B
MKC McCormick & Company, Incorporated Q2 2018 2018-06-28 C+
ATI Allegheny Technologies Incorporated Q1 2018 2018-04-24 B
INST Instructure's Q4 2017 2018-02-12 B+
HOLX Hologic, Inc. Q4 2017 2017-11-08 D
GNTX Gentex Corporation Q3 2017 2017-10-20 B
MXL MaxLinear, Inc. Q2 2017 2017-08-08 C+
BIIB Biogen Inc. Q2 2017 2017-07-25 B
CNS Cohen & Steers, Inc. Q2 2017 2017-07-20 B
PTC PTC Inc. Q3 2017 2017-07-19 C+
PLAB Photronics, Inc. Q2 2017 2017-05-17 C+
IONS Ionis Pharmaceuticals, Inc. Q1 2017 2017-05-09 C
ICFI ICF International, Inc. Q1 2017 2017-05-06 B+
PPG PPG Industries, Inc. Q1 2017 2017-04-20 C
MDLZ Mondelez International, Inc. Q4 2016 2017-02-07 C
BP BP p.l.c. Q4 2016 2017-02-07 B+
NTCT NetScout Systems, Inc. Q2 2017 2016-10-27 D
F Ford Motor Company Q3 2016 2016-10-27 B+
MAT Mattel, Inc. Q3 2016 2016-10-19 C
NDSN Nordson Corporation Q3 2016 2016-08-23 A
VRNS Varonis Systems, Inc. Q2 2016 2016-08-09 B+
NWSA News Corporation Q2 2016 2016-08-08 C+
CGNX Cognex Corporation Q2 2016 2016-08-01 A
TRV The Travelers Companies, Inc. Q2 2016 2016-07-21 C+
LBTYK Liberty Global's Q1 2016 2016-05-10 C+
GOGO Gogo Inc. Q1 2016 2016-05-06 C+
ESE ESCO Technologies Inc. Q2 2016 2016-05-03 A
DD DuPont de Nemours, Inc. Q1 2016 2016-04-26 B+
HD The Home Depot, Inc. Q4 2015 2016-02-23 A
SAN Banco Santander, S.A. Q4 2015 2016-01-27 B
HXL Hexcel Corporation Q4 2015 2016-01-22 B+

How the model reasoned

ICFI · Q1 2017 → YESThe question is: Does management point to a growth-bearing development that they previously told investors to expect, and now it's arriving with current activity, but still early with most contributio...YES Management explicitly references the themes from their February 2017 full-year earnings call (only two months prior), noting that the January-February pickup they had highlighted there continued through March. They then point to concrete current-period activity: ICF Olson won over $75 million in new revenue since acquisition (neither firm could have won independently), added substantial new-account wins in Q1, and saw its qualified pipeline rise significantly above year-end 2016 levels. John Wasson confirms the new projects and retainers are now lining up, with strong Q1 wins and momentum from added staff. Sudhakar states they expect mid-single-digit growth this 2017 and sequential improvement, while reiterating confidence in the medium-term outlook. The language makes clear the ramp is still early—H2 comparisons and most of the contribution lie ahead—matching the three-part pattern for this growth-bearing development. No other item in the call satisfies all three criteria as cleanly.
HOLX · Q4 2017 → YESThe question is about whether management points to a growth-bearing development they previously told investors to expect, and now it's arriving with current activity, but still early. YES The transcript shows a clear three-part pattern for international growth. Management explicitly references its prior expectation: “while we thought that international would be a double-digit grower by 2018, we've actually delivered on that promise a year earlier than anticipated.” In the just-reported Q4, they confirm the development with concrete activity 17.5% international growth (excluding Cynosure and blood), the sixth consecutive quarter of double-digit growth for molecular internationally, and Panther shipments exceeding prior-year levels. They also state it is still early with most contribution ahead: “we've actually delivered on that promise a year earlier,” and they hope investors remember this 2017 success story as they evaluate Cynosure 2.
PTC · Q3 2017 → YESThe question is about whether management points to a growth-bearing development they previously told investors to expect, and now it's arriving with current activity, but still early. YES Management explicitly references its prior long-term growth ambition for IoT (30-40% bookings growth, consistent with the faster-growing IoT market) as part of its double-digit overall plan, which it had communicated as the target to achieve sustainable growth. In the current quarter, it confirms this is materializing with 40%+ of IoT bookings from customer expansions, six-figure deals growing sequentially and year-over-year, and specific closed expansions with leading food/beverage, aerospace/defense, and medical device companies, plus strong contribution from these. It further conveys the development remains early by noting customers are "generally still in the early days of their IoT journeys" with "adoption is gaining momentum" and "further stages" (e.g.

More from the question bank

Customers coming back on their ownEscape velocity out of a small baseCounterparties stepping up before the numberFresh evidence outrunning the reported numbeCash cost of the waitSequential re-ratingAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.